{"schema_version":"secwatch.filing_event.v1","accession":"0000950170-22-011752","form_type":"8-K","ticker":"KZR","cik":"0001645666","company_name":"Kezar Life Sciences, Inc.","filed_at":"2022-06-16T23:59:59+00:00","discovered_at":"2026-05-14T18:04:01.620231+00:00","generated_at":"2026-06-25T01:17:54.342688+00:00","sec_items":["5.07"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.1,"calibrated_materiality_score":0.1,"confidence":"high","headline":"Kezar Life Sciences reports 2022 annual meeting voting results","bullets":["Stockholders elected Elizabeth Garner, Michael Kauffman, and Courtney Wallace as Class I directors until 2025.","Garner received 32,387,898 votes for; Kauffman 29,866,607; Wallace 45,460,015.","Ratification of KPMG as independent auditor for FY2022 passed with 56,166,095 for, 12,016 against, 1,946 abstain.","No other proposals were voted on; all nominees and auditor ratified."],"urls":{"canonical":"https://secwatch.observer/filing/0000950170-22-011752","json":"https://secwatch.observer/filing/0000950170-22-011752.json","markdown":"https://secwatch.observer/filing/0000950170-22-011752.md","text":"https://secwatch.observer/filing/0000950170-22-011752.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1645666/000095017022011752/0000950170-22-011752-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1645666/000095017022011752/kzr-20220615.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-25T01:17:54.342688+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}